Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.48 USD | 0.00% | -14.54% | -26.08% |
May. 10 | Top Midday Decliners | MT |
May. 10 | Sector Update: Health Care Stocks Advance Friday Afternoon | MT |
Financials (USD)
Sales 2024 * | 1.25B | Sales 2025 * | 1.49B | Capitalization | 2.62B |
---|---|---|---|---|---|
Net income 2024 * | 71M | Net income 2025 * | 99M | EV / Sales 2024 * | 1.88 x |
Net cash position 2024 * | 263M | Net cash position 2025 * | 481M | EV / Sales 2025 * | 1.44 x |
P/E ratio 2024 * |
39.1
x | P/E ratio 2025 * |
27.9
x | Employees | 565 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.47% |
Latest transcript on Progyny, Inc.
1 day | +0.29% | ||
1 week | -16.88% | ||
Current month | -14.29% | ||
1 month | -19.65% | ||
3 months | -32.43% | ||
6 months | -13.69% | ||
Current year | -26.09% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Anevski
CEO | Chief Executive Officer | 56 | 16-12-31 |
Michael Sturmer
PSD | President | 47 | 21-02-28 |
Mark Livingston
DFI | Director of Finance/CFO | 58 | 19-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Beth Seidenberg
BRD | Director/Board Member | 67 | 10-04-30 |
Kevin Gordon
BRD | Director/Board Member | 61 | 19-09-30 |
Norman Payson
BRD | Director/Board Member | 49 | 16-12-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.12% | 430 M€ | -.--% | ||
0.10% | 43 M€ | +4.15% | ||
0.07% | 115 M€ | +2.02% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 27.48 | +0.02% | 443 954 |
24-05-14 | 27.48 | +0.29% | 1,813,823 |
24-05-13 | 27.4 | -0.47% | 2,054,538 |
24-05-10 | 27.53 | -15.29% | 9,000,761 |
24-05-09 | 32.5 | +1.06% | 1,698,031 |
Delayed Quote Nasdaq, May 14, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.09% | 2.62B | |
+13.37% | 124B | |
+15.69% | 98.41B | |
-24.75% | 41.51B | |
+3.58% | 41.02B | |
-3.14% | 20.51B | |
-18.70% | 1.34B | |
+7.13% | 506M |
- Stock Market
- Equities
- PGNY Stock